DexCom (DXCM) – Press Releases
-
Dexcom Publishes Annual Sustainability Report
-
Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
-
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
-
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
-
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
-
Dexcom Announces Upcoming Conference Presentation
-
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
-
Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
-
Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
-
Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland
-
A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2
-
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook
-
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Synchron Appoints Andy Rasdal to Board of Directors
-
Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump
-
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
-
Dexcom Announces Upcoming Conference Presentation
-
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day
-
Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don’t Understand the Benefits1-2
-
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program
-
Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada
-
Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
-
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
-
Dexcom Canada and RxFood Corporation Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition
-
Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program
-
Dexcom Unlocks Access to Real-Time CGM for a Further Half a Million People With Diabetes in France
-
Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany
-
Dexcom Announces Upcoming Conference Presentations
-
Dexcom Appoints Rimma Driscoll to Board of Directors
-
Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive Year
-
Dexcom Reports Second Quarter 2023 Financial Results
-
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
-
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
-
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
-
Dexcom Updates Long-Range Financial Targets
-
Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System
-
New Study Shows That 84% of People With Diabetes Struggle With Mental Health¹
-
Dexcom to Host Investor Day on June 23, 2023
-
Dexcom Announces Upcoming Conference Presentation
-
Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
-
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
-
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
-
Dexcom Reports First Quarter 2023 Financial Results
-
Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
-
Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
-
Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
-
Dexcom Publishes Annual Sustainability Report
-
Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Opera
-
Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors
-
DexCom Comments on SVB Relationship
Back to DXCM Stock Lookup
